Invesco’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$286K Buy
255,372
+41,869
+20% +$46.9K ﹤0.01% 3378
2025
Q1
$169K Buy
213,503
+104,569
+96% +$82.6K ﹤0.01% 3536
2024
Q4
$180K Buy
108,934
+7,056
+7% +$11.6K ﹤0.01% 3519
2024
Q3
$357K Sell
101,878
-218
-0.2% -$763 ﹤0.01% 3344
2024
Q2
$335K Sell
102,096
-863,335
-89% -$2.83M ﹤0.01% 3438
2024
Q1
$7.09M Buy
965,431
+835,977
+646% +$6.14M ﹤0.01% 2017
2023
Q4
$484K Buy
129,454
+3,867
+3% +$14.5K ﹤0.01% 3227
2023
Q3
$266K Buy
125,587
+6,791
+6% +$14.4K ﹤0.01% 3488
2023
Q2
$565K Sell
118,796
-4,465
-4% -$21.3K ﹤0.01% 3162
2023
Q1
$703K Buy
123,261
+75,782
+160% +$432K ﹤0.01% 3071
2022
Q4
$479K Sell
47,479
-3,687
-7% -$37.2K ﹤0.01% 3270
2022
Q3
$1.15M Buy
51,166
+3,616
+8% +$81K ﹤0.01% 2862
2022
Q2
$1.18M Sell
47,550
-967,567
-95% -$24M ﹤0.01% 2909
2022
Q1
$39.4M Buy
1,015,117
+131,838
+15% +$5.11M 0.01% 1108
2021
Q4
$51.7M Buy
883,279
+762,832
+633% +$44.6M 0.01% 1033
2021
Q3
$7.14M Sell
120,447
-763,687
-86% -$45.3M ﹤0.01% 2196
2021
Q2
$76.7M Buy
884,134
+206,998
+31% +$18M 0.02% 919
2021
Q1
$55.8M Buy
677,136
+253,280
+60% +$20.9M 0.01% 1013
2020
Q4
$38.5M Buy
423,856
+102,309
+32% +$9.3M 0.01% 1113
2020
Q3
$12.9M Buy
321,547
+296,773
+1,198% +$11.9M ﹤0.01% 1528
2020
Q2
$850K Sell
24,774
-122,688
-83% -$4.21M ﹤0.01% 2853
2020
Q1
$3.28M Buy
+147,462
New +$3.28M ﹤0.01% 2116
2019
Q3
Sell
-50,107
Closed -$1.02M 3636
2019
Q2
$1.02M Sell
50,107
-3,072
-6% -$62.4K ﹤0.01% 3047
2019
Q1
$934K Sell
53,179
-17,683
-25% -$311K ﹤0.01% 3040
2018
Q4
$909K Sell
70,862
-515,916
-88% -$6.62M ﹤0.01% 3007
2018
Q3
$9.56M Buy
586,778
+404,542
+222% +$6.59M ﹤0.01% 1731
2018
Q2
$2.07M Buy
+182,236
New +$2.07M ﹤0.01% 2733
2017
Q3
Sell
-20,736
Closed -$67K 3644
2017
Q2
$67K Buy
20,736
+8,271
+66% +$26.7K ﹤0.01% 3658
2017
Q1
$57K Buy
+12,465
New +$57K ﹤0.01% 3682